FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387191005> ?p ?o ?g. }

• W4387191005 endingPage "106474" @default.
• W4387191005 startingPage "106474" @default.
• W4387191005 abstract "Resistance to radio and chemotherapy in Glioblastoma (GBM) is correlated with its malignancy, invasiveness, and aggressiveness. The Rho GTPase pathway plays important roles in these processes, but its involvement in the GBM response to genotoxic treatments remains unsolved. Inhibition of this signaling pathway has emerged as a promising approach for the treatment of CNS injuries and diseases, proving to be a strong candidate for therapeutic approaches. To this end, Rho-associated kinases (ROCK), classic downstream effectors of small Rho GTPases, were targeted for pharmacological inhibition using Y-27632 in GBM cells, expressing the wild-type or mutated p53 gene, and exposed to genotoxic stress by gamma ionizing radiation (IR) or cisplatin (PT). The use of the ROCK inhibitor (ROCKi) had opposite effects in these cells: in cells expressing wild-type p53, ROCKi reduced survival and DNA repair capacity (reduction of γH2AX foci and accumulation of strand breaks) after stress promoted by IR or PT; in cells expressing the mutant p53 protein, both treatments promoted longer survival and more efficient DNA repair, responses further enhanced by ROCKi. The target DNA repair mechanisms of ROCK inhibition were, respectively, an attenuation of NHEJ and NER pathways in wild-type p53 cells, and a stimulation of HR and NER pathways in mutant p53 cells. These effects were accompanied by the formation of reactive oxygen species (ROS) induced by genotoxic stress only in mutant p53 cells but potentiated by ROCKi and reversed by p53 knockdown. N-acetyl-L-cysteine (NAC) treatment or Rac1 knockdown completely eliminated ROCKi's p53-dependent actions, since ROCK inhibition specifically elevated Rac-GTP levels only in mutant p53 cells. Combining IR or PT and ROCKi treatments broadens our understanding of the sensitivity and resistance of, respectively, GBM expressing wild-type or mutant p53 to genotoxic agents. Our proposal may be a determining factor in improving the efficiency and assertiveness of CNS antitumor therapies based on ROCK inhibitors. SIGNIFICANCE: The use of ROCK inhibitors in association with radio or chemotherapy modulates GBM resistance and sensitivity depending on the p53 activity, suggesting the potential value of this protein as therapeutic target for tumor pre-sensitization strategies." @default.
• W4387191005 created "2023-09-30" @default.
• W4387191005 creator A5049162453 @default.
• W4387191005 creator A5089651035 @default.
• W4387191005 date "2023-11-01" @default.
• W4387191005 modified "2023-10-08" @default.
• W4387191005 title "ROCK inhibition reduces the sensitivity of mutant p53 glioblastoma to genotoxic stress through a Rac1-driven ROS production" @default.
• W4387191005 cites W1973766462 @default.
• W4387191005 cites W2007471444 @default.
• W4387191005 cites W2043520273 @default.
• W4387191005 cites W2065896238 @default.
• W4387191005 cites W2070280275 @default.
• W4387191005 cites W2080366427 @default.
• W4387191005 cites W2114843025 @default.
• W4387191005 cites W2125747506 @default.
• W4387191005 cites W2149441684 @default.
• W4387191005 cites W2164277862 @default.
• W4387191005 cites W2166676058 @default.
• W4387191005 cites W2171365654 @default.
• W4387191005 cites W2179828787 @default.
• W4387191005 cites W2209502372 @default.
• W4387191005 cites W2215155470 @default.
• W4387191005 cites W2413931725 @default.
• W4387191005 cites W2507760628 @default.
• W4387191005 cites W2520842278 @default.
• W4387191005 cites W2529495446 @default.
• W4387191005 cites W2555040012 @default.
• W4387191005 cites W2605955768 @default.
• W4387191005 cites W2763159133 @default.
• W4387191005 cites W2782834724 @default.
• W4387191005 cites W2801494499 @default.
• W4387191005 cites W2802589812 @default.
• W4387191005 cites W2885448129 @default.
• W4387191005 cites W2887889442 @default.
• W4387191005 cites W2888870133 @default.
• W4387191005 cites W2890896123 @default.
• W4387191005 cites W2892274591 @default.
• W4387191005 cites W2899422206 @default.
• W4387191005 cites W2941846657 @default.
• W4387191005 cites W2947829255 @default.
• W4387191005 cites W2951678012 @default.
• W4387191005 cites W2999339913 @default.
• W4387191005 cites W3007389146 @default.
• W4387191005 cites W3013792721 @default.
• W4387191005 cites W3048145652 @default.
• W4387191005 cites W3064036078 @default.
• W4387191005 cites W3081723185 @default.
• W4387191005 cites W3123368520 @default.
• W4387191005 cites W3132985612 @default.
• W4387191005 cites W3139480400 @default.
• W4387191005 cites W4220720534 @default.
• W4387191005 cites W4221022657 @default.
• W4387191005 cites W4313478267 @default.
• W4387191005 cites W4366742995 @default.
• W4387191005 cites W933087622 @default.
• W4387191005 doi "https://doi.org/10.1016/j.biocel.2023.106474" @default.
• W4387191005 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37778694" @default.
• W4387191005 hasPublicationYear "2023" @default.
• W4387191005 type Work @default.
• W4387191005 citedByCount "0" @default.
• W4387191005 crossrefType "journal-article" @default.
• W4387191005 hasAuthorship W4387191005A5049162453 @default.
• W4387191005 hasAuthorship W4387191005A5089651035 @default.
• W4387191005 hasConcept C104317684 @default.
• W4387191005 hasConcept C134935766 @default.
• W4387191005 hasConcept C143065580 @default.
• W4387191005 hasConcept C143425029 @default.
• W4387191005 hasConcept C173396325 @default.
• W4387191005 hasConcept C185592680 @default.
• W4387191005 hasConcept C190283241 @default.
• W4387191005 hasConcept C207583985 @default.
• W4387191005 hasConcept C2776192174 @default.
• W4387191005 hasConcept C2779717556 @default.
• W4387191005 hasConcept C502942594 @default.
• W4387191005 hasConcept C552990157 @default.
• W4387191005 hasConcept C55493867 @default.
• W4387191005 hasConcept C62478195 @default.
• W4387191005 hasConcept C86803240 @default.
• W4387191005 hasConcept C95444343 @default.
• W4387191005 hasConceptScore W4387191005C104317684 @default.
• W4387191005 hasConceptScore W4387191005C134935766 @default.
• W4387191005 hasConceptScore W4387191005C143065580 @default.
• W4387191005 hasConceptScore W4387191005C143425029 @default.
• W4387191005 hasConceptScore W4387191005C173396325 @default.
• W4387191005 hasConceptScore W4387191005C185592680 @default.
• W4387191005 hasConceptScore W4387191005C190283241 @default.
• W4387191005 hasConceptScore W4387191005C207583985 @default.
• W4387191005 hasConceptScore W4387191005C2776192174 @default.
• W4387191005 hasConceptScore W4387191005C2779717556 @default.
• W4387191005 hasConceptScore W4387191005C502942594 @default.
• W4387191005 hasConceptScore W4387191005C552990157 @default.
• W4387191005 hasConceptScore W4387191005C55493867 @default.
• W4387191005 hasConceptScore W4387191005C62478195 @default.
• W4387191005 hasConceptScore W4387191005C86803240 @default.
• W4387191005 hasConceptScore W4387191005C95444343 @default.
• W4387191005 hasLocation W43871910051 @default.
• W4387191005 hasLocation W43871910052 @default.
• W4387191005 hasOpenAccess W4387191005 @default.

• next